Jay Strum Email & Phone Number

Dr. Jay Strum is the Co-Founder and Chief Scientific Officer at Incyclix Bio (previously ARC Therapeutics). Prior to joining Incyclix Bio, Dr. Strum was the founding Chief Scientific Officer at G1 Therapeutics where he also served as President and Director leading the company from concept to a VC backed start up. He is the co-inventor of trilaciclib, the first in class CDK4/6 inhibitor for mitigation of chemotherapy-induced myelosuppression and lerociclib, an oral CDK4/6 inhibitor currently in Phase 2 clinical trials. Prior to G1, Dr. Strum was a Director at GSK where he led efforts in translating scientific discoveries into improved therapies across multiple therapeutic areas. He has co-authored over 50 scientific publications and is an inventor on 35 issued US patents and more than 350 patents worldwide. Dr. Strum received his PhD in Biochemistry from Wake Forest University and completed his postgraduate training in Molecular Cancer Biology at Duke University.

Listed skills include Drug Discovery, Molecular Biology, Pharmaceutical Industry, Biochemistry, and 42 others.